1 minute read

Grant application success

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians who are diagnosed with cancer, including their families and carers. Cancer Australia aims to decrease the effect of cancer, address inequalities and improve outcomes for people affected by cancer. This is done by leading and coordinating national, evidence-based interventions to maintain a continuity of medical care delivered to the patient.

Cancer research and clinical trials are vital to increase our understanding of how to prevent cancer, develop new approaches to detecting, diagnosing and treating cancers, and improve support and care for people affected by cancer.

Australia is a world leader in cancer research and the Australian Government is committed to ensuring Australia remains at the forefront of research, treatment and the care of people affected by cancer at a local and international level.

Cancer Australia continues to fund priority cancer research through a number of initiatives, including: the awarding of research grants through Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS) and providing funding support to four National Technical Services as well as Australia’s 14 Collaborative Cancer Clinical Trials Groups, of which ANZUP is one. ANZUP is extremely grateful for the continued support received from Cancer Australia. The awarded grant will provide valuable infrastructure funding allowing ANZUP to continue to develop clinical trials. One mechanism adopted by ANZUP to build the clinical trials portfolio is through our Concept Development Workshops. At these workshops clinical trial ideas, conceived by ANZUP members, are discussed initially as concepts. These ideas are then fleshed out with the assistance of experienced members, as well as with broad multidisciplinary input and consumer engagement, with the hope of future trial development and execution.

Looking to the future, it is essential that Australia has a sufficient cancer research workforce and appropriate infrastructure to take advantage of rapid advances in our understanding of cancer to achieve improved outcomes for all Australians affected by this disease.

This article is from: